GENNBIO INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 389 KRW | -0.51% |
|
-.--% | -2.99% |
| Mar. 21 | GenNBio Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | GenNBio Inc. cancelled the transaction announced on March 22, 2023 | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 92,467 | 152,536 | 270,430 | 172,088 | 85,148 | 22,911 |
| Enterprise Value (EV) 1 | 100,168 | 172,597 | 284,873 | 185,430 | 128,688 | 52,557 |
| P/E ratio | -15 x | -2.92 x | -12.3 x | -5.12 x | -2.16 x | -1.41 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 13.1 x | 6.94 x | 22.8 x | 19.3 x | 9.08 x | 4.33 x |
| EV / Revenue | 14.2 x | 7.86 x | 24 x | 20.8 x | 13.7 x | 9.94 x |
| EV / EBITDA | 88.2 x | -10.7 x | -28.6 x | -16.4 x | -11.5 x | -4.15 x |
| EV / FCF | 32 x | -4.4 x | -37.4 x | -3.99 x | -3.25 x | -1.93 x |
| FCF Yield | 3.13% | -22.7% | -2.67% | -25.1% | -30.8% | -51.9% |
| Price to Book | 2.8 x | 5.99 x | 5.98 x | 1.81 x | 1.31 x | 0.39 x |
| Nbr of stocks (in thousands) | 18,743 | 23,710 | 28,975 | 41,820 | 44,580 | 57,135 |
| Reference price 2 | 4,933 | 6,433 | 9,333 | 4,115 | 1,910 | 401.0 |
| Announcement Date | 3/21/19 | 3/22/21 | 3/23/21 | 3/21/22 | 4/9/23 | 3/21/24 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 7,043 | 21,968 | 11,846 | 8,895 | 9,373 | 5,289 |
| EBITDA 1 | 1,136 | -16,159 | -9,974 | -11,335 | -11,158 | -12,659 |
| EBIT 1 | -2,356 | -18,446 | -13,875 | -14,896 | -14,049 | -16,513 |
| Operating Margin | -33.46% | -83.97% | -117.13% | -167.47% | -149.89% | -312.23% |
| Earnings before Tax (EBT) 1 | -5,149 | -42,262 | -17,713 | -33,199 | -23,538 | -16,101 |
| Net income 1 | -5,105 | -45,299 | -21,308 | -30,806 | -37,793 | -15,670 |
| Net margin | -72.48% | -206.2% | -179.88% | -346.34% | -403.22% | -296.28% |
| EPS 2 | -328.2 | -2,207 | -761.6 | -802.9 | -885.4 | -283.9 |
| Free Cash Flow 1 | 3,134 | -39,261 | -7,610 | -46,508 | -39,634 | -27,282 |
| FCF margin | 44.5% | -178.72% | -64.24% | -522.88% | -422.87% | -515.86% |
| FCF Conversion (EBITDA) | 275.84% | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/21/19 | 3/22/21 | 3/23/21 | 3/21/22 | 4/9/23 | 3/21/24 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 7,701 | 20,061 | 14,442 | 13,342 | 43,540 | 29,646 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 6.778 x | -1.241 x | -1.448 x | -1.177 x | -3.902 x | -2.342 x |
| Free Cash Flow 1 | 3,134 | -39,261 | -7,610 | -46,508 | -39,634 | -27,282 |
| ROE (net income / shareholders' equity) | -21.5% | -147% | -49% | -46.5% | -31% | -24.1% |
| ROA (Net income/ Total Assets) | -2.43% | -14.2% | -9.21% | -7.77% | -6.31% | -8.08% |
| Assets 1 | 209,662 | 319,965 | 231,261 | 396,499 | 599,066 | 193,984 |
| Book Value Per Share 2 | 1,763 | 1,074 | 1,560 | 2,272 | 1,458 | 1,019 |
| Cash Flow per Share 2 | 931.0 | 852.0 | 426.0 | 91.20 | 48.30 | 0.1200 |
| Capex 1 | 335 | 23,532 | 9,046 | 50,594 | 24,857 | 2,460 |
| Capex / Sales | 4.75% | 107.12% | 76.37% | 568.82% | 265.21% | 46.51% |
| Announcement Date | 3/21/19 | 3/22/21 | 3/23/21 | 3/21/22 | 4/9/23 | 3/21/24 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -2.99% | 21.06M | |
| +12.13% | 43.19B | |
| -3.33% | 12.18B | |
| +14.10% | 5.67B | |
| -5.29% | 4.36B | |
| +0.37% | 3.97B | |
| -1.18% | 2.41B | |
| +7.10% | 2.09B | |
| -3.64% | 1.57B | |
| +3.67% | 1.45B |
- Stock Market
- Equities
- A072520 Stock
- Financials GenNBio Inc.